Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

ACCENT MICROCELL LTD. 2023-24 Annual Report Analysis
Fri, 16 Aug

ACCENT MICROCELL LTD. has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

ACCENT MICROCELL LTD. Income Statement Analysis

  • Operating income during the year rose 24.4% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 103.0% YoY during the fiscal. Operating profit margins witnessed a fall and down at 15.7% in FY24 as against 9.6% in FY23.
  • Depreciation charges increased by 7.8% and finance costs decreased by 54.8% YoY, respectively.
  • Other income grew by 45.8% YoY.
  • Net profit for the year grew by 146.6% YoY.
  • Net profit margins during the year grew from 6.2% in FY23 to 12.3% in FY24.

ACCENT MICROCELL LTD. Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 1,973 2,455 24.4%
Other income Rs m 25 36 45.8%
Total Revenues Rs m 1,998 2,491 24.7%
Gross profit Rs m 190 385 103.0%
Depreciation Rs m 41 44 7.8%
Interest Rs m 25 11 -54.8%
Profit before tax Rs m 148 365 146.8%
Tax Rs m 26 64 147.7%
Profit after tax Rs m 122 302 146.6%
Gross profit margin % 9.6 15.7
Effective tax rate % 17.3 17.4
Net profit margin % 6.2 12.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

ACCENT MICROCELL LTD. Balance Sheet Analysis

  • The company's current liabilities during FY24 down at Rs 465 million as compared to Rs 562 million in FY23, thereby witnessing an decrease of -17.3%.
  • Long-term debt down at Rs 15 million as compared to Rs 55 million during FY23, a fall of 72.6%.
  • Current assets rose 115% and stood at Rs 2 billion, while fixed assets rose 25% and stood at Rs 414 million in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 2 billion as against Rs 1 billion during FY23, thereby witnessing a growth of 89%.

ACCENT MICROCELL LTD. Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 504 1,638 224.9
 
Current Liabilities Rs m 562 465 -17.3
Long-term Debt Rs m 55 15 -72.6
Total Liabilities Rs m 1,132 2,135 88.5
 
Current assets Rs m 802 1,721 114.7
Fixed Assets Rs m 330 414 25.4
Total Assets Rs m 1,132 2,135 88.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



ACCENT MICROCELL LTD. Cash Flow Statement Analysis

  • ACCENT MICROCELL LTD.'s cash flow from operating activities (CFO) during FY24 stood at Rs 113 million, an improvement of 49.6% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -823 million, an improvement of 1,937.7% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs 723 million, an improvement of 1,774% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs 13 million from the Rs -8 million net cash flows seen during FY23.

ACCENT MICROCELL LTD. Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 76 113 49.6%
Cash Flow from Investing Activities Rs m -40 -823 -
Cash Flow from Financing Activities Rs m -43 723 -
Net Cash Flow Rs m -8 13 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for ACCENT MICROCELL LTD.

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 14.3, an improvement from the EPS of Rs 9.5 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 264.5, stands at 18.4 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.4 times, while the price to sales ratio stands at 2.3 times.
  • The company's price to cash flow (P/CF) ratio stood at 17.9 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 152.5 116.7
TTM Earnings per share Rs 9.5 14.3
Diluted earnings per share Rs 5.8 14.3
Price to Cash Flow x 0.0 17.9
TTM P/E ratio x 0.0 18.4
Price / Book Value ratio x 0.0 3.8
Market Cap Rs m 0 6,187
Dividends per share (Unadj.) Rs 0.8 1.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for ACCENT MICROCELL LTD.

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 3.7x during FY24, from 1.4x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 32.9x during FY24, from 6.8x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 18.4% during FY24, from 24.3% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 22.8% during FY24, from 31.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 14.7% during FY24, from 13.0% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 1.4 3.7
Debtors’ Days Days 562 800
Interest coverage x 6.8 32.9
Debt to equity ratio x 0.1 0.0
Return on assets % 13.0 14.7
Return on equity % 24.3 18.4
Return on capital employed % 31.0 22.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how ACCENT MICROCELL LTD. has performed over the last 5 years, please visit here.

ACCENT MICROCELL LTD. Share Price Performance

Over the last one year, ACCENT MICROCELL LTD. share price has moved down from Rs 0.0 to Rs 0.0, registering a loss of Rs 0.0 or around 0.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 41,058.7 (up 0.7%). Over the last one year it has moved up from 28,042.9 to 41,058.7, a gain of 13,016 points (up 46.4%).

Overall, the NIFTY 50 is up 0.8% over the year.

(To know more, check out historical annual results for ACCENT MICROCELL LTD. and quarterly results for ACCENT MICROCELL LTD.)

Annual Report FAQs

What is the current share price of ACCENT MICROCELL LTD.?

ACCENT MICROCELL LTD. currently trades at Rs 238.5 per share. You can check out the latest share price performance of ACCENT MICROCELL LTD. here...

What was the revenue of ACCENT MICROCELL LTD. in FY24? How does it compare to earlier years?

The revenues of ACCENT MICROCELL LTD. stood at Rs 2,491 m in FY24, which was up 24.7% compared to Rs 1,998 m reported in FY23.

ACCENT MICROCELL LTD.'s revenue has grown from Rs 1,348 m in FY21 to Rs 2,491 m in FY24.

Over the past 4 years, the revenue of ACCENT MICROCELL LTD. has grown at a CAGR of 22.7%.

What was the net profit of ACCENT MICROCELL LTD. in FY24? How does it compare to earlier years?

The net profit of ACCENT MICROCELL LTD. stood at Rs 302 m in FY24, which was up 146.6% compared to Rs 122 m reported in FY23.

This compares to a net profit of Rs 59 m in FY22 and a net profit of Rs 48 m in FY21.

Over the past 4 years, ACCENT MICROCELL LTD. net profit has grown at a CAGR of 84.5%.

What does the cash flow statement of ACCENT MICROCELL LTD. reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of ACCENT MICROCELL LTD. reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 113 m as compared to Rs 76 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -823 m as compared to Rs -40 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs 723 m as compared to Rs -43 m in FY23.

Here's the cash flow statement of ACCENT MICROCELL LTD. for the past 4 years.

(Rs m)FY21FY22FY23FY24
From Operations5014976113
From Investments-63-43-40-823
From Financial Activity-22-97-43723
Net Cashflow-349-813

What does the Key Ratio analysis of ACCENT MICROCELL LTD. reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of ACCENT MICROCELL LTD. reveals:

  • Operating profit margins witnessed a fall and down at 15.7% in FY24 as against 9.6% in FY23.
  • Net profit margins grew from 6.2% in FY23 to 12.3% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.1 in FY23.

Here's the ratio/financial analysis of ACCENT MICROCELL LTD. for the past 4 years.

 FY21FY22FY23FY24
Operating Profit Margin (%)8.17.89.615.7
Net Profit Margin (%)3.63.66.212.3
Debt to Equity Ratio (x)0.70.20.10.0

 

Equitymaster requests your view! Post a comment on "ACCENT MICROCELL LTD. 2023-24 Annual Report Analysis". Click here!